Does strength training protect muscle better than protein alone on a GLP-1?
Key takeaways
Dr. Linda's take
This question comes up once women get past the first few months and start thinking about what kind of body they are actually building. The scale is moving. Now they want to know what is leaving.
I want to answer the question as asked, and then tell you why the question itself is slightly the wrong shape. Strength training and protein are not two competing answers to one problem. They are two different jobs. The evidence we have says do both, and if you have to start with one, start with the one that has the bigger and more direct signal.
How much of the weight I am losing is actually muscle?
Enough to take seriously, and less than the internet suggests.
In a 2026 meta-analysis of 20 randomized controlled trials comprising 15,782 participants, lean mass constituted 25% to 39% of total weight lost with incretin agonists, at 35.2% with semaglutide, 25.4% with tirzepatide, and 26.8% with liraglutide.
An independent network meta-analysis of 22 randomized trials landed in the same place: lean mass loss comprised approximately 25% of the total weight loss, while the relative lean mass, defined as percentage change from baseline, was unaffected. Two separate research groups, roughly the same answer. That is what a real finding looks like.
And in the tirzepatide SURMOUNT-1 body-composition substudy, of the body weight lost, approximately 75% was fat mass and 25% was lean mass for both tirzepatide and placebo.
Is the medication doing this to me?
No, and this is the single most important thing in this article.
In that same 2026 meta-analysis, lifestyle interventions showed comparable proportional lean mass loss at 26.2%, and the authors concluded that the proportion of weight lost as lean mass is broadly comparable between incretin-based pharmacotherapy and lifestyle interventions. The comparison was not statistically significant.
Look again at the SURMOUNT substudy above: the same 75-25 split showed up in the placebo group.
This is what weight loss does. It is not something the drug is doing to you. Losing weight means losing some of the tissue that was carrying that weight around, and that has been true of every method anyone has ever tried. The medication did not put you in a special category of danger. It just got you to the crossroads faster.
That reframe matters, because fear makes people do foolish things, like stopping abruptly or under-eating, both of which make the muscle question worse rather than better. If you are in perimenopause specifically, see does a GLP-1 cause muscle loss in perimenopause.
Does strength training actually protect muscle?
This is the strongest evidence in the whole piece.
Across 34 randomized trials in 1,455 people, adding exercise to calorie restriction produced a mean difference of +0.87 kg of fat-free mass compared with calorie restriction alone, and on average exercise prevented nearly half of the fat-free mass loss, at 45.7%.
Within that analysis, mixed training yielded the largest effect at +1.20 kg, followed by strength training at +0.83 kg, while endurance training alone fell just short of statistical significance.
Two honest notes. First, mixed training actually scored higher than strength training alone, and the authors reported that subgroup testing found no significant differences between training modes. So the accurate statement is not "lifting is proven best." It is that training clearly works, and lifting is a well-supported way to do it. Second, this research was in people losing weight by calorie restriction, not in people taking these medications.
There is also a reason to think resistance training does more than defend. Supervised resistance exercise training interventions lasting more than 10 weeks can elicit large increases in lean mass of about 3 kg and strength of about 25% in men and women, which is why the authors of a Diabetes Care review proposed that tailored resistance exercise training be recommended as an adjunct to incretin therapy.
Does protein do the same job?
It helps. It helps less, and it helps differently.
Across 24 trials in 1,063 people, a higher-protein energy-restricted diet mitigated reductions in fat-free mass by 0.43 kg compared with a standard-protein diet. That is a real effect and a modest one.
Where protein shines is on top of training. In 49 studies with 1,863 participants, protein supplementation increased fat-free mass gains by 0.30 kg during resistance training, and protein supplementation beyond total protein intakes of 1.62 g per kg per day resulted in no further training-induced gains in fat-free mass. There is a ceiling, and past it you are just buying expensive urine. We put numbers on the target in how much protein do you need on a GLP-1 to protect muscle.
The most pointed finding is in women. In a meta-analysis in women aged 55 and over, whey protein improved biceps curl strength and lower-limb lean mass in the subgroup that did resistance training, while in the subgroup without resistance training, no significant effect on muscle strength or lean mass was revealed.
Protein without training did nothing measurable for muscle in those women. That is as close to an answer to the title question as the literature currently gets.
So which one wins?
Here is where I have to be disciplined, because it would be easy to overclaim.
Nobody has directly compared them in people taking these medications. The trial designed to answer exactly this is underway: a 232-person randomized trial at the Dasman Diabetes Institute is assigning adults with obesity starting semaglutide or tirzepatide to control, resistance exercise, protein supplementation, or combined resistance exercise and protein. It has not reported.
I want to be explicit about a comparison I am not making. The exercise number above (+0.87 kg) and the protein number (+0.43 kg) come from different meta-analyses, with different populations and different comparators. Lining them up as though one beat the other in a race would be a sleight of hand. They point in a consistent direction; they are not a head-to-head result.
What we do have is a real head-to-head of exercise versus medication versus both. In a randomized trial in adults with obesity, a combination strategy decreased body-fat percentage by 3.9 percentage points, approximately twice the decrease in the exercise group at 1.7 points and the liraglutide group at 1.9 points, and the authors concluded a strategy combining exercise and liraglutide therapy improved healthy weight loss maintenance more than either treatment alone. That trial used liraglutide and an aerobic-led program, so it does not settle the lifting-versus-protein question. It settles a different and useful one: both beats either.
What does this mean for me?
General education, not a prescription for you. But the shape of the evidence is unusually clear:
Questions worth bringing to your clinician: is resistance training safe and appropriate for me right now, what protein target makes sense given my kidneys and my other conditions, and should we be measuring anything to know whether this is working? Bone matters here too, which we cover in does a GLP-1 affect bone density after menopause. To see whether one of these medications fits your situation, try our eligibility quiz.
The honest bottom line
Does strength training protect muscle better than protein alone? On the evidence we have, training is the stronger and more direct lever, protein amplifies it, and in postmenopausal women protein by itself did not show a measurable muscle benefit. The definitive trial is running and has not reported.
Here is the part I want you to keep. The muscle you are worried about is not being taken from you by a medication. It is the ordinary cost of losing weight by any means, and it is the one cost you have real leverage over. That is not a warning. That is the good news.
Frequently asked questions
Has anyone directly compared strength training with protein on a GLP-1?
Not yet. The trial designed to answer exactly this is underway: a 232-person randomized trial at the Dasman Diabetes Institute is assigning adults with obesity starting semaglutide or tirzepatide to control, resistance exercise, protein supplementation, or combined resistance exercise and protein. It has not reported.
How much of GLP-1 weight loss is muscle?
In a 2026 meta-analysis of 20 randomized controlled trials comprising 15,782 participants, lean mass constituted 25% to 39% of total weight lost with incretin agonists, at 35.2% with semaglutide, 25.4% with tirzepatide, and 26.8% with liraglutide.
Is the medication causing the muscle loss?
The evidence says this is what weight loss does generally. In that same 2026 meta-analysis, lifestyle interventions showed comparable proportional lean mass loss at 26.2%, and the authors concluded that the proportion of weight lost as lean mass is broadly comparable between incretin-based pharmacotherapy and lifestyle interventions.
Does strength training actually preserve muscle?
Across 34 randomized trials in 1,455 people, adding exercise to calorie restriction produced a mean difference of +0.87 kg of fat-free mass compared with calorie restriction alone, and on average exercise prevented nearly half of the fat-free mass loss, at 45.7%. That research was in people losing weight by calorie restriction rather than on these medications.
How much protein is enough?
In 49 studies with 1,863 participants, protein supplementation increased fat-free mass gains by 0.30 kg during resistance training, and protein supplementation beyond total protein intakes of 1.62 g per kg per day resulted in no further training-induced gains in fat-free mass. Your own target is a conversation for your clinician, particularly if you have kidney disease.
Can I just take protein and skip the gym?
In a meta-analysis in women aged 55 and over, whey protein improved biceps curl strength and lower-limb lean mass in the subgroup that did resistance training, while in the subgroup without resistance training, no significant effect on muscle strength or lean mass was revealed.
References
1. BMJ open (2026). LEAN mass Preservation with Resistance Exercise and Protein during semaglutide and tirzepatide therapy (LEAN-PREP study): a protocol for a randomised controlled trial. PubMed PMID 42020128. https://pubmed.ncbi.nlm.nih.gov/42020128/ (Accessed 2026-07-17).
2. Diabetes, obesity & metabolism (2026). Lean Mass Changes With Incretin Therapy Versus Lifestyle Intervention: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. PubMed PMID 41877354. https://pubmed.ncbi.nlm.nih.gov/41877354/ (Accessed 2026-07-17).
3. Diabetes, obesity & metabolism (2026). Effects of Calorie Restriction With and Without Strength, Endurance or Mixed Training on Fat-Free and Skeletal Muscle Mass in Overweight or Obese Individuals-A Systematic Review With Pairwise Meta-Analysis and Network Meta-Analysis of Randomized Controlled Studies. PubMed PMID 42144246. https://pubmed.ncbi.nlm.nih.gov/42144246/ (Accessed 2026-07-17).
4. Nutrients (2022). Effect of Whey Protein Supplementation in Postmenopausal Women: A Systematic Review and Meta-Analysis. PubMed PMID 36235862. https://pubmed.ncbi.nlm.nih.gov/36235862/ (Accessed 2026-07-17).
5. Metabolism: clinical and experimental (2025). Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis. PubMed PMID 39719170. https://pubmed.ncbi.nlm.nih.gov/39719170/ (Accessed 2026-07-17).
6. Diabetes, obesity & metabolism (2025). Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. PubMed PMID 39996356. https://pubmed.ncbi.nlm.nih.gov/39996356/ (Accessed 2026-07-17).
7. Diabetes care (2024). Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?. PubMed PMID 38687506. https://pubmed.ncbi.nlm.nih.gov/38687506/ (Accessed 2026-07-17).
8. The American journal of clinical nutrition (2012). Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials. PubMed PMID 23097268. https://pubmed.ncbi.nlm.nih.gov/23097268/ (Accessed 2026-07-17).
9. British journal of sports medicine (2018). A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. PubMed PMID 28698222. https://pubmed.ncbi.nlm.nih.gov/28698222/ (Accessed 2026-07-17).
10. The New England journal of medicine (2021). Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined. PubMed PMID 33951361. https://pubmed.ncbi.nlm.nih.gov/33951361/ (Accessed 2026-07-17).
---
*This article is general education and is not medical advice. It cannot tell you what is right for your body. Talk with a licensed clinician about your own situation.*
*Written and clinically reviewed by Dr. Linda Moleon, MD. Last reviewed 2026-07-17.*
Keep reading
What happens to your blood sugar if you stop a GLP-1 with prediabetes?
When people stopped a GLP-1 in the trials, weight came back and HbA1c rose in step with it. But the reversal was not automatic, and the famous 84.1% normoglycemia figure is an on-treatment number. Here is what the withdrawal data actually shows.
Can a GLP-1 change your periods in perimenopause?
Nobody has run the trial on GLP-1s and menstrual bleeding in perimenopause, and perimenopause changes cycles by itself. Here is the indirect path through weight and ovulation, plus the one label warning about birth control that is worth acting on.
Does a GLP-1 help with PCOS acne and unwanted hair growth?
GLP-1 medications do lower testosterone in women with PCOS. Whether that clears your skin or slows hair growth is a different question, and the honest answer is that the trials came back inconclusive. Here is what is real, what is not yet shown, and what to ask.
How much protein do you need on a GLP-1 to protect muscle?
There is no official protein requirement written for people taking a GLP-1, and the numbers in circulation are borrowed from weight-loss and sarcopenia research rather than proven in these patients. Here is what the trial body-composition data actually showed, and why a smaller appetite makes the target harder to hit.
Does a GLP-1 raise your risk of thyroid cancer?
Every GLP-1 label carries a boxed warning about thyroid C-cell tumors, and the fear it creates is real. Here is what the rodent studies actually showed, why the human question is still genuinely open, and who the labels say should not take these medicines.
Do you qualify for a GLP-1 if you have prediabetes but not diabetes?
Prediabetes is not an FDA-approved indication for any GLP-1, so qualification runs through the chronic weight management criteria instead. Here is how those criteria actually read on the current labels, and why prediabetes sits in a real but unofficial position.